狮头股份：2025年前三季度净利润约-395万元

Group 1 - The core point of the article is that Lionhead Co., Ltd. reported its third-quarter performance, showing a slight increase in revenue but a net loss for the period [1] - For the first three quarters of 2025, the company's revenue was approximately 330 million yuan, reflecting a year-on-year increase of 3.3% [1] - The net profit attributable to shareholders was a loss of approximately 3.95 million yuan, with a basic earnings per share loss of 0.0172 yuan [1] Group 2 - As of the report, Lionhead Co., Ltd. has a market capitalization of 2.6 billion yuan [2] - The article also highlights the broader context of the Chinese innovative drug market, noting that overseas licensing has generated 80 billion US dollars this year [2] - There is a discussion on the contrasting performance of the secondary and primary markets in the biopharmaceutical sector, with the secondary market being active while the primary market faces challenges in fundraising [2]